Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
Carlota Dobaño, Rebeca Santano, Alfons Jiménez, et al.
Translational research (2021) Vol. 232, pp. 60-74
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
Masaud Shah, Hyun Goo Woo
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 216
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Natalia Ortega, Marta Ribes, Marta Vidal, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 132
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 105
The COVID-19 pandemic in the African continent
Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 100
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers
Gemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
EBioMedicine (2022) Vol. 75, pp. 103805-103805
Open Access | Times Cited: 67
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Anu Haveri, Nina Ekström, Anna Solastie, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 90
Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response
Chun-Yang Lin, Joshua Wolf, David C. Brice, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 83-96.e4
Open Access | Times Cited: 86
Evaluation of antibody response after COVID‐19 vaccination of healthcare workers
Elif Bilge Uysal, Sibel Gümüş, Bayhan Bektöre, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 1060-1066
Open Access | Times Cited: 75
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
Tom Woudenberg, Stéphane Pelleau, François Anna, et al.
EBioMedicine (2021) Vol. 70, pp. 103495-103495
Open Access | Times Cited: 63
Fluorescent nanodiamond-based spin-enhanced lateral flow immunoassay for detection of SARS-CoV-2 nucleocapsid protein and spike protein from different variants
Wesley Wei‐Wen Hsiao, Neha Sharma, Trong‐Nghia Le, et al.
Analytica Chimica Acta (2022) Vol. 1230, pp. 340389-340389
Open Access | Times Cited: 38
COVID-19 Vaccines: Current and Future Perspectives
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 608-608
Open Access | Times Cited: 37
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile
Rocío Rubio, Ruth Aguilar, Mariona Bustamante, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Immuno-μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints
Julián Guercetti, Marc Alorda, Luciano D. Sappia, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts
Carlota Dobaño, Selena Alonso, Marta Vidal, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies
Masaud Shah, Hyun Goo Woo
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
Investigation of SARS-CoV-2 nucleocapsid protein interaction with a specific antibody by combined spectroscopic ellipsometry and quartz crystal microbalance with dissipation
Ieva Plikusienė, Vincentas Mačiulis, Silvija Juciute, et al.
Journal of Colloid and Interface Science (2022) Vol. 626, pp. 113-122
Open Access | Times Cited: 21
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
Anna Solastie, Tuomo Nieminen, Nina Ekström, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 11
Long-Term Exposure to Air Pollution and COVID-19 Vaccine Antibody Response in a General Population Cohort (COVICAT Study, Catalonia)
Manolis Kogevinas, Marianna Karachaliou, Ana Espinosa, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 4
Open Access | Times Cited: 10
SARS‐CoV‐2 seroprevalence among blood donors in Uganda: 2019–2022
Evan M. Bloch, Dorothy Kyeyune, Jodie L. White, et al.
Transfusion (2023) Vol. 63, Iss. 7, pp. 1354-1365
Open Access | Times Cited: 10
Detection of SARS-CoV-2 N protein using AgNPs-modified aligned silicon nanowires BioSERS chip
Sadok Kouz, Amal Raouafi, Awatef Ouhibi, et al.
RSC Advances (2024) Vol. 14, Iss. 17, pp. 12071-12080
Open Access | Times Cited: 3
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection
Andrés G. Abril, Jose Alejandre, Anaís Mariscal, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan
Kiran Iqbal Masood, Shama Qaiser, Syed Hani Abidi, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
Jiong Wang, Dongmei Li, Andrew Cameron, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 3, pp. 474-484
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top